Enzon Pharmaceuticals Inc (ENZN) Financial Statements (2026 and earlier)

Company Profile

Business Address	333 EAST BUTTERFIELD ROAD, SUITE 400 LOMBARD, IL 60148
State of Incorp.	DE
Fiscal Year End	December 31
Industry (SIC)	2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info	Complete Financial Analysis Financial Benchmarking

	12/31/2025 Q4	9/30/2025 Q3	6/30/2025 Q2	3/31/2025 Q1	12/31/2024 Q4	9/30/2024 Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments	42,574	43,256	44,294	44,966	46,859	46,633
Cash and cash equivalent	42,574	43,256	44,294	44,966	46,859	46,633
Receivables
Inventory, net of allowances, customer advances and progress billings
Inventory
Other current assets	239	411	444	555	293	337
Total current assets:	42,813	43,667	44,738	45,521	47,152	46,970
Noncurrent Assets
Operating lease, right-of-use asset
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization
Intangible asset, including goodwill, after accumulated amortization
Goodwill
Intangible asset, excluding goodwill, after accumulated amortization
Deferred income tax assets		26	42		17	306
Other noncurrent assets
Other undisclosed noncurrent assets
Total noncurrent assets:		26	42		17	306
TOTAL ASSETS:	42,813	43,693	44,780	45,521	47,169	47,276
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities	731	540	803	554	403	438
Accounts payable	331	331	331	331	331	331
Accrued liabilities	400	209	472	223	72	107